Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE

Abroad (travel likely)RecruitingPHASE1

Conditions

Systemic Lupus Erythematosus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China
Contact: Study coordinator (Lingyun Sun) · lingyunsun2012@163.com · 13705186409

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Systemic Lupus Erythematosus · Idiopathic Inflammatory Myopathies · Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE1

Anniston, United States · Birmingham, United States

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

Systemic Lupus Erythematosus (SLE) · Rheumatoid Arthritis (RA)

Abroad (travel likely)RecruitingPHASE1

Brisbane, Australia · Melbourne, Australia

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1

Allen, United States · San Antonio, United States

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Systemic Lupus Erythematosus · Lupus Nephritis (LN) · Sjogren's Syndrome

Abroad (travel likely)RecruitingPHASE1

Bengbu, China